Earningsreport

Q3/2024 9/30/2024 EPS -0.170 ZacksConsensus -0.200 ActVsEst 0.030 - Beat

Cue Biopharma, Inc.  (CUE) 
US:NASDAQ Investor Relations: cuebiopharma.gcs-web.com/news-releases